DOJ to file charges against several generic drugmakers - CNBC

On Thursday, November 3 2016, the DOJ announced that it expected to file charges against several generic drugmakers by year-end. The expected charges involved both US and overseas drug companies, and involve drug pricing issues such as possible price collusion on several different drugs.

This CNBC video discusses the charges and possible effects on drug company stocks.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.